Sinikka Green

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

G. Ralph Corey, Samantha Good, Hai Jiang et al. · Clinical Infectious Diseases · 2014 · 218 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

William O’Riordan, Sinikka Green, J. Scott Overcash et al. · New England Journal of Medicine · 2019 · 151 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus

G. Ralph Corey, Francis F. Arhin, Matthew A. Wikler et al. · International Journal of Antimicrobial Agents · 2016 · 34 citations

Pharmacy, Dermatology, Pharmacotherapy +17

Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy

David Adams, Jonas Wixner, Michael Polydefkis et al. · JAMA Neurology · 2025 · 31 citations · Full text

Medicine, Neurology, Pharmacotherapy +13